This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Dec 1;81(5):1593-4.

doi: 10.1016/j.ijrobp.2011.06.1962.

Benefit of optimizing the dose to the carotid in hypofractionated stereotactic body reirradiation?

Juliette Thariat, Pierre-Yves Marcy, Alexis Lacout

PMID: 22115562
DOI: 10.1016/j.ijrobp.2011.06.1962

Comment

Benefit of optimizing the dose to the carotid in hypofractionated stereotactic body reirradiation?

Juliette Thariat et al. Int J Radiat Oncol Biol Phys. 2011.

. 2011 Dec 1;81(5):1593-4.

doi: 10.1016/j.ijrobp.2011.06.1962.

Authors

Juliette Thariat, Pierre-Yves Marcy, Alexis Lacout

PMID: 22115562
DOI: 10.1016/j.ijrobp.2011.06.1962

No abstract available

PubMed Disclaimer

Comment on

ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer.
McDonald MW, Lawson J, Garg MK, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yeung AR, Yom SS, Beitler JJ; Expert Panel on Radiation Oncology-Head and Neck Cancer. McDonald MW, et al. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1292-8. doi: 10.1016/j.ijrobp.2011.02.014. Epub 2011 Apr 27. Int J Radiat Oncol Biol Phys. 2011. PMID: 21530100 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information